Drug details
Dexlido (dexamethasone sodium phosphate for injection)
type of Corticosteroids, Anti-Inflammatory Agents
Dexlido (dexamethasone sodium phosphate, lidocaine hydrochloride, povidinepovidone iodine kit) is a corticosteroid used for endocrine disorders, rheumatic disorders, collagen diseases, dermatologic (skin) diseases, allergic states, ophthalmic (eye) diseases, gastrointestinal diseases, hematologic (blood) disorders, neoplastic diseases (cancers), edematous states, tuberculous meningitis with subarachnoid block or impending block when used concurrently with appropriate antituberculous chemotherapy, trichinosis with neurologic or myocardial involvement, diagnostic testing of adrenocortical hyperfunction, and cerebral edema associated with primary or metastatic brain tumor, craniotomy, or head injury.
The drug is often used to treat Meningitis .
This drug may have the following side effects:
- skin redness,
- nausea,
- weight gain,
- headache,
- muscle weakness,
- bulging eyes,
- pancreatitis,
- high blood pressure (hypertension),
- increased sweating,
- bruising,
- increased appetite,
- fluid retention,
- osteoporosis,
- thin fragile skin,
- hiccups
- glaucoma,
- sodium retention,
- congestive heart failure in susceptible patients,
- potassium loss,
- hypokalemic alkalosis,
- steroid muscle disease,
- loss of muscle mass,
- vertebral compression fractures,
- aseptic necrosis of femoral and humeral heads,
- tendon rupture,
- fracture of long bones,
- peptic ulcer with possible perforation and hemorrhage,
- perforation of the small and large bowel, particularly in patients with IBD,
- abdominal distention,
- ulcerative esophagitis,
- impaired wound healing
- may suppress reactions to skin tests,
- burning or tingling, especially in the perineal area (after iv injection),
- other skin reactions, such as allergic dermatitis, hives, angioneurotic edema,
- convulsions,
- increased intracranial pressure,
- vertigo (spinning sensation),
- psychic disturbances,
- menstrual irregularities
- development of cushingoid state
- suppression of growth in pediatric patients
- secondary adrenocortical and pituitary unresponsiveness,
- decreased carbohydrate tolerance
- manifestations of latent diabetes mellitus
- increased requirements for insulin or oral hypoglycemic agents in diabetics
- unwanted excess hair growth,
- cataracts,
- increased intraocular pressure,
- exophthalmos,
- retinopathy of prematurity,
- negative nitrogen balance due to protein catabolism,
- myocardial rupture following recent heart attack,
- hypertrophic cardiomyopathy in low birth weight infants,
- anaphylactoid or hypersensitivity reactions,
- blood blots,
- feeling unwell (malaise) and,